Inventor · disambiguated record
Luc Teyton
Also filed as: TEYTON LUC
10 granted patents·3 pending applications·45 citations·filing 2003–2020
86Inventor score
Top patents by PatentIndex Score
13 records- 0191US7989423B26″-amino-6″-deoxygalactosylceramidesSCRIPPS RESEARCH INST·Filed 2009·Granted Aug 2, 2011·16 cites·19 claims
- 0286US7645873B26″-amino-6″-deoxygalactosylceramidesSCRIPPS RESEARCH INST·Filed 2003·Granted Jan 12, 2010·18 cites·10 claims
- 0380US8227581B2Modified α-galactosyl ceramides for staining and stimulating natural killer T cellsSAVAGE PAUL B·Filed 2007·Granted Jul 24, 2012·4 cites·28 claims
- 0476US7794722B2Adjuvants and methods of useSCRIPPS RESEARCH INST·Filed 2007·Granted Sep 14, 2010·2 cites·9 claims
- 0575US8445272B2Method of stimulating NKT with 6″-amino-6″-deoxygalactosylceramidesSAVAGE PAUL B·Filed 2011·Granted May 21, 2013·2 cites·16 claims
- 0674US9295722B2Bacterial glycolipid activation of CD1d-restricted NKT cellsSAVAGE PAUL B·Filed 2006·Granted Mar 29, 2016·2 cites·10 claims
- 0771US9045512B26″-amino-6″-deoxygalactosylceramidesSCRIPPS RESEARCH INST·Filed 2013·Granted Jun 2, 2015·1 cites·11 claims
- 0850US8932594B2Adjuvants and methods of useTEYTON LUC·Filed 2010·Granted Jan 13, 2015·0 cites·24 claims
- 0950US2023043394A1Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitorsUNIV DER JOHANNES GUTENBERG UNIV MAINZ·Filed 2020·Application pending·0 cites
- 1049US8765692B2Modified-galactosyl ceramides for staining and stimulating natural killer T cellsSAVAGE PAUL B·Filed 2012·Granted Jul 1, 2014·0 cites·34 claims
- 1148US2017029454A1Nkt cell ligands and methods of useSCRIPPS RESEARCH INST·Filed 2014·Application pending·0 cites
- 1245US7998739B2Methods of activating NKT cellsSCIPPS RES INST·Filed 2005·Granted Aug 16, 2011·0 cites·12 claims
- 1341US2011082106A1Methods of activating nkt cellsUNIV CHICAGO·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →